Search results
Forget 'Stranger Danger.' Here's What We Should Really Teach Kids To Keep Them Safe.
HuffPost Life via Yahoo News· 3 days agoThese days, however, top child safety experts are more likely to recommend teaching the concept of...
Fire crews battling brush fire on Yakima Greenway near Sarg Hubbard Park
Apple Valley News Now· 2 days agoYAKIMA, Wash. -- Yakima fire crews are on scene of a brush fire in the Yakima Greenway.
Dan Fitzgerald gets why KU baseball missed NCAA tournament, but would be open to expansion
The Topeka Capital-Journal· 6 days agoAs the Men’s College World Series is unfolding this month, Kansas baseball coach Dan Fitzgerald is...
Cantor Fitzgerald Reaffirms Overweight Rating for Skye Bioscience (NASDAQ:SKYE)
ETF DAILY NEWS· 4 days agoCantor Fitzgerald restated their overweight rating on shares of Skye Bioscience (NASDAQ:SKYE – Free...
Amarin (NASDAQ:AMRN) Rating Reiterated by Cantor Fitzgerald
ETF DAILY NEWS· 3 days agoAmarin (NASDAQ:AMRN – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at Cantor Fitzgerald in a research report issued to clients ...
Cantor Fitzgerald Reiterates “Overweight” Rating for Novo Nordisk A/S (NYSE:NVO)
ETF DAILY NEWS· 4 days agoNovo Nordisk A/S (NYSE:NVO – Get Free Report)‘s stock had its “overweight” rating reaffirmed by stock analysts at Cantor Fitzgerald in a report released on Monday, Benzinga ...
Intellia Therapeutics’ (NTLA) “Overweight” Rating Reaffirmed at Cantor Fitzgerald
ETF DAILY NEWS· 3 days ago‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a report issued on Tuesday, Benzinga reports. Cantor Fitzgerald
Rivian Automotive (NASDAQ:RIVN) Given Overweight Rating at Cantor Fitzgerald
ETF DAILY NEWS· 5 days agoCantor Fitzgerald reiterated their overweight rating on shares of Rivian Automotive (NASDAQ:RIVN – Free Report) in a research report sent to investors on Monday, Benzinga ...
Cantor Fitzgerald Reiterates “Overweight” Rating for Celldex Therapeutics (NASDAQ:CLDX)
ETF DAILY NEWS· 3 days agoCelldex Therapeutics (NASDAQ:CLDX – Get Free Report)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a research report issued to clients and investors ...
Cantor Fitzgerald Reiterates “Overweight” Rating for Perspective Therapeutics (NYSE:CATX)
ETF DAILY NEWS· 3 days agoPerspective Therapeutics (NYSE:CATX – Get Free Report)‘s stock had its “overweight” rating reissued...